Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC; SPIRE Cardiovascular Outcome Investigators.

N Engl J Med. 2017 Apr 20;376(16):1527-1539. doi: 10.1056/NEJMoa1701488. Epub 2017 Mar 17.

2.

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.

EAS Familial Hypercholesterolaemia Studies Collaboration, Vallejo-Vaz AJ, Akram A, Kondapally Seshasai SR, Cole D, Watts GF, Hovingh GK, Kastelein JJ, Mata P, Raal FJ, Santos RD, Soran H, Freiberger T, Abifadel M, Aguilar-Salinas CA, Alnouri F, Alonso R, Al-Rasadi K, Banach M, Bogsrud MP, Bourbon M, Bruckert E, Car J, Ceska R, Corral P, Descamps O, Dieplinger H, Do CT, Durst R, Ezhov MV, Fras Z, Gaita D, Gaspar IM, Genest J, Harada-Shiba M, Jiang L, Kayikcioglu M, Lam CS, Latkovskis G, Laufs U, Liberopoulos E, Lin J, Lin N, Maher V, Majano N, Marais AD, März W, Mirrakhimov E, Miserez AR, Mitchenko O, Nawawi H, Nilsson L, Nordestgaard BG, Paragh G, Petrulioniene Z, Pojskic B, Reiner Ž, Sahebkar A, Santos LE, Schunkert H, Shehab A, Slimane MN, Stoll M, Su TC, Susekov A, Tilney M, Tomlinson B, Tselepis AD, Vohnout B, Widén E, Yamashita S, Catapano AL, Ray KK.

Atheroscler Suppl. 2016 Dec;22:1-32. doi: 10.1016/j.atherosclerosissup.2016.10.001. Epub 2016 Dec 7.

3.

Familial defective apolipoprotein B-100: A review.

Andersen LH, Miserez AR, Ahmad Z, Andersen RL.

J Clin Lipidol. 2016 Nov - Dec;10(6):1297-1302. doi: 10.1016/j.jacl.2016.09.009. Epub 2016 Sep 22. Review.

PMID:
27919345
4.

Familial defective apolipoprotein B-100: a tale of twin mutations.

Andersen LH, Andersen RL, Miserez AR.

J Clin Lipidol. 2016 Jul-Aug;10(4):1050-1051. doi: 10.1016/j.jacl.2016.04.007. Epub 2016 Apr 22. No abstract available.

PMID:
27578140
5.
6.

Quantitative EEG and apolipoprotein E-genotype improve classification of patients with suspected Alzheimer's disease.

Hatz F, Benz N, Hardmeier M, Zimmermann R, Rueegg S, Schindler C, Miserez AR, Gschwandtner U, Monsch AU, Fuhr P.

Clin Neurophysiol. 2013 Nov;124(11):2146-52. doi: 10.1016/j.clinph.2013.04.339. Epub 2013 Jun 17.

PMID:
23786792
7.

Zurich Fabry study - prevalence of Fabry disease in young patients with first cryptogenic ischaemic stroke or TIA.

Sarikaya H, Yilmaz M, Michael N, Miserez AR, Steinmann B, Baumgartner RW.

Eur J Neurol. 2012 Nov;19(11):1421-6. doi: 10.1111/j.1468-1331.2012.03737.x. Epub 2012 Jun 11.

PMID:
22680335
8.

Clinical and pathological features of a non-crystalline form of Schnyder corneal dystrophy.

Arnold-Wörner N, Goldblum D, Miserez AR, Flammer J, Meyer P.

Graefes Arch Clin Exp Ophthalmol. 2012 Aug;250(8):1241-3. doi: 10.1007/s00417-012-1975-y. Epub 2012 Mar 14. No abstract available.

PMID:
22411127
9.

For debate: substituting placebo controls in long-term Alzheimer's prevention trials.

Spiegel R, Berres M, Miserez AR, Monsch AU; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Res Ther. 2011 Mar 21;3(2):9. doi: 10.1186/alzrt68.

10.

The triglyceride to high-density lipoprotein-cholesterol ratio in adolescence and subsequent weight gain predict nuclear magnetic resonance-measured lipoprotein subclasses in adulthood.

Weiss R, Otvos JD, Sinnreich R, Miserez AR, Kark JD.

J Pediatr. 2011 Jan;158(1):44-50. doi: 10.1016/j.jpeds.2010.07.002.

PMID:
20801459
11.

Adiponectin and lipoprotein particle size.

Weiss R, Otvos JD, Flyvbjerg A, Miserez AR, Frystyk J, Sinnreich R, Kark JD.

Diabetes Care. 2009 Jul;32(7):1317-9. doi: 10.2337/dc09-0084. Epub 2009 Apr 23.

12.

Leptin, insulin, and obesity-related phenotypes: genetic influences on levels and longitudinal changes.

Friedlander Y, Meiner V, Sharon N, Siscovick DS, Miserez AR.

Obesity (Silver Spring). 2009 Jul;17(7):1458-60. doi: 10.1038/oby.2008.672. Epub 2009 Feb 12.

13.

Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas.

Sivasankaran B, Degen M, Ghaffari A, Hegi ME, Hamou MF, Ionescu MC, Zweifel C, Tolnay M, Wasner M, Mergenthaler S, Miserez AR, Kiss R, Lino MM, Merlo A, Chiquet-Ehrismann R, Boulay JL.

Cancer Res. 2009 Jan 15;69(2):458-65. doi: 10.1158/0008-5472.CAN-08-2610.

14.

Clinical course of neuropathologically confirmed frontal-variant Alzheimer's disease.

Taylor KI, Probst A, Miserez AR, Monsch AU, Tolnay M.

Nat Clin Pract Neurol. 2008 Apr;4(4):226-32. doi: 10.1038/ncpneuro0746. Epub 2008 Feb 19.

PMID:
18285751
15.

Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumors.

Boulay JL, Miserez AR, Zweifel C, Sivasankaran B, Kana V, Ghaffari A, Luyken C, Sabel M, Zerrouqi A, Wasner M, Van Meir E, Tolnay M, Reifenberger G, Merlo A.

PLoS One. 2007 Jun 27;2(6):e576.

16.

Statins induce differentiation and cell death in neurons and astroglia.

März P, Otten U, Miserez AR.

Glia. 2007 Jan 1;55(1):1-12.

PMID:
16998865
18.

The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients.

Durst R, Jansen A, Erez G, Bravdo R, Butbul E, Ben Avi L, Shpitzen S, Lotan C, Leitersdorf E, Defesche J, Friedlander Y, Meiner V, Miserez AR.

Atherosclerosis. 2006 Dec;189(2):443-50. Epub 2006 Feb 8.

PMID:
16466730
19.

Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.

Berneis K, Jeanneret C, Muser J, Felix B, Miserez AR.

Metabolism. 2005 Feb;54(2):227-34.

PMID:
15690318

Supplemental Content

Loading ...
Support Center